Combination of sasa quelpaertensis nakai leaf extract and cisplatin suppresses the cancer stemness and invasion of human lung cancer cells

Integrative Cancer Therapies

Volumn 13, Issue 6, 2014, Pages 529-540

  Kim, Mina ^a   Kim, Yoo Sun ^a   Kim, Kyung Mi ^a   Ko, Hee Chul ^b   Kim, Se Jae ^b   Kim, Jung Hyun ^c   Kim, Yuri ^a  

^a Ewha Womans University   (South Korea)

^b Jeju National University   (South Korea)

^c Chung Ang University   (South Korea)

Author keywords

cancer stem cells; cisplatin; invasion; lung cancer; Sasa quelpaertensis Nakai leaf extract

Indexed keywords

BIOLOGICAL MARKER; CD44V ANTIGEN; CISPLATIN; GELATINASE A; HERMES ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; SASA QUELPAERTENSIS EXTRACT; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

A549 CELL LINE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STEM CELL; CELL GROWTH; CELL MIGRATION; CELL RENEWAL; CLONOGENESIS; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; LUNG METASTASIS; MEDICINAL PLANT; METASTASIS INHIBITION; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; SASA QUELPAERTENSIS; TUMOR INVASION; CELL MOTION; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PATHOLOGY; SASA; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; PLANT EXTRACTS; PLANT LEAVES; SASA;

EID: 84921028961     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735414534462     Document Type: Article

References (66)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 ; 60: 277-300
2. Gazdar AF, Brambilla E. Preneoplasia of lung cancer. Cancer Biomark. 2010 ; 9: 385-396
3. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007 ; 75: 56-63
4. Erridge SC, Moller H, Price A, Brewster D. International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol. 2007 ; 4: 570-577
5. Chen JS, Wang Q, Fu XH, et al. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9. Hepatol Res. 2009 ; 39: 177-186
6. Murakami M, Ichisaka T, Maeda M, et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol. 2004 ; 24: 6710-6718
7. Lee S, Choi EJ, Jin C, Kim DH. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol. 2005 ; 97: 26-34
8. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006 ; 66: 9339-9344
9. Reya T. Regulation of hematopoietic stem cell self-renewal. Recent Prog Horm Res. 2003 ; 58: 283-295
10. Ribacka C, Pesonen S, Hemminki A. Cancer, stem cells, and oncolytic viruses. Ann Med. 2008 ; 40: 496-505
11. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005 ; 65: 10946-10951
12. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005 ; 65: 5506-5511
13. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res. 2005 ; 65: 3025-3029
14. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003 ; 63: 5821-5828
15. Eramo A, Lotti F, Sette G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008 ; 15: 504-514
16. Ko YH, Won HS, Jeon EK, et al. Prognostic significance of CD44s expression in resected non-small cell lung cancer. BMC Cancer. 2011 ; 11: 340
17. Leung EL, Fiscus RR, Tung JW, et al. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One. 2010 ; 5: e14062
18. Zhu H, Mitsuhashi N, Klein A, et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells. 2006 ; 24: 928-935
19. Kitamura H, Okudela K, Yazawa T, Sato H, Shimoyamada H. Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer. Lung Cancer. 2009 ; 66: 275-281
20. Slivko SF, Stets VR. Effect of sex hormones on pain sensitivity and on the dynamics of the analgesic effect of morphine. Anesteziol Reanimatol. 1978 ; (1). 12-14
21. Namazi H. Zoledronic acid and survival in patients with metastatic bone disease from lung cancer and elevated markers of osteoclast activity: a novel molecular mechanism. J Thorac Oncol. 2008 ; 3: 943-944
22. Brummer O, Athar S, Riethdorf L, Loning T, Herbst H. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study. Virchows Arch. 1999 ; 435: 566-573
23. Das S, Mandal M, Chakraborti T, Mandal A, Chakraborti S. Structure and evolutionary aspects of matrix metalloproteinases: a brief overview. Mol Cell Biochem. 2003 ; 253: 31-40
24. Cox G, O'Byrne KJ. Matrix metalloproteinases and cancer. Anticancer Res. 2001 ; 21: 4207-4219
25. Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med. 2006 ; 355: 983-991
26. Tsang RY, Al-Fayea T, Au HJ. Cisplatin overdose: toxicities and management. Drug Saf. 2009 ; 32: 1109-1122
27. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol. 2008 ; 6: 1-18
28. Okabe S, Takeuchi K, Takagi K, Shibata M. Stimulatory effect of the water extract of bamboo grass (Folin solution) on gastric acid secretion in pylorus-ligated rats. Jpn J Pharmacol. 1975 ; 25: 608-609
29. Yang JH, Lim HS, Heo YR. Sasa borealis leaves extract improves insulin resistance by modulating inflammatory cytokine secretion in high fat diet-induced obese C57/BL6J mice. Nutr Res Pract. 2010 ; 4: 99-105
30. Ren M, Reilly RT, Sacchi N. Sasa health exerts a protective effect on Her2/NeuN mammary tumorigenesis. Anticancer Res. 2004 ; 24: 2879-2884
31. Shibata M, Yamatake Y, Sakamoto M, Kanamori M, Takagi K. Pharmacological studies on bamboo grass (1). Acute toxicity and anti-inflammatory and antiulcerogenic activities of water-soluble fraction(Folin) extracted from Sasa albomarginata Makino et Shibata. Nihon Yakurigaku Zasshi. 1975 ; 71: 481-490
32. Tsunoda S, Yamamoto K, Sakamoto S, Inoue H, Nagasawa H. Effects of Sasa Health, extract of bamboo grass leaves, on spontaneous mammary tumourigenesis in SHN mice. Anticancer Res. 1998 ; 18: 153-158
33. Shibata M, Fojii M, Yamaguchi R. Pharmacological studies on bamboo grass. IV. Toxicological and pharmacological effects of the extract (FIII) obtained from Sasa albomarginata Makino et Shibata (author's transl). Yakugaku Zasshi. 1979 ; 99: 663-668
34. Kitamura K, Saitoh T, Matsuo A, Suyama Y. Development of microsatellite markers for the dwarf bamboo species Sasa cernua and Sasa kurilensis (Poaceae) in northern Japan. Mol Ecol Resour. 2009 ; 9: 1470-1472
35. Kang SI, Shin HS, Kim HM, et al. Anti-obesity properties of a Sasa quelpaertensis extract in high-fat diet-induced obese mice. Biosci Biotechnol Biochem. 2012 ; 76: 755-761
36. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986 ; 89: 271-277
37. Kim Y, Lin Q, Zelterman D, Yun Z. Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res. 2009 ; 69: 9271-9280
38. Kranz D, Dobbelstein M. Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy. Cancer Res. 2006 ; 66: 10274-10280
39. Lee YC, Lin HH, Hsu CH, Wang CJ, Chiang TA, Chen JH. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway. Eur J Pharmacol. 2010 ; 632: 23-32
40. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A. 2003 ; 100: 15178-15183
41. Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003 ; 17: 1253-1270
42. Gonzalez-Arriaga P, Pascual T, Garcia-Alvarez A, Fernandez-Somoano A, Lopez-Cima MF, Tardon A. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. BMC Cancer. 2012 ; 12: 121
43. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008 ; 3: e3077
44. Amin AR, Kucuk O, Khuri FR, Shin DM. Perspectives for cancer prevention with natural compounds. J Clin Oncol. 2009 ; 27: 2712-2725
45. Herbst RS, Arquette M, Shin DM, et al. Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. J Clin Oncol. 2005 ; 23: 5578-5587
46. Dhingra HM, Valdivieso M, Carr DT, et al. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer. J Clin Oncol. 1985 ; 3: 176-183
47. Lechner JF, Reen RK, Dombkowski AA, et al. Effects of a black raspberry diet on gene expression in the rat esophagus. Nutr Cancer. 2008 ; 60: 61-69
48. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem. 2007 ; 18: 427-442
49. Kakarala M, Brenner DE, Korkaya H, et al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat. 2010 ; 122: 777-785
50. Kallifatidis G, Rausch V, Baumann B, et al. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut. 2009 ; 58: 949-963
51. Nishimura N, Hartomo TB, Pham TV, et al. Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells. Environ Health Prev Med. 2012 ; 17: 246-251
52. Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX. Transl Oncol. 2009 ; 2: 321-328
53. Kallifatidis G, Labsch S, Rausch V, et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther. 2011 ; 19: 188-195
54. Hung JY, Hsu YL, Li CT, et al. 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/mTOR pathway in human non-small cell lung cancer A549 cells. J Agric Food Chem. 2009 ; 57: 9809-9816
55. Morrison BJ, Steel JC, Morris JC. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells. PLoS One. 2012 ; 7: e49752
56. Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS. Cancer stem cells in breast: current opinion and future challenges. Pathobiology. 2008 ; 75: 75-84
57. Wu Y, Wu PY. CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev. 2009 ; 18: 1127-1134
58. Zhang L, Dermawan K, Jin M, et al. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy. Clin Immunol. 2008 ; 129: 219-229
59. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007 ; 1: 555-567
60. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001 ; 414: 105-111
61. McDonnell S, Morgan M, Lynch C. Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans. 1999 ; 27: 734-740
62. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci. 2002 ; 3: 409-421
63. Choi YJ, Lim HS, Choi JS, et al. Blockade of chronic high glucose-induced endothelial apoptosis by Sasa borealis bamboo extract. Exp Biol Med (Maywood). 2008 ; 233: 580-591
64. Lin J, Li P, Chen KS. Advance in studies on anti-tumor activity of polysaccharides in latest five years. Zhongguo Zhong Yao Za Zhi. 2013 ; 38: 1116-1125
65. Zhao M, Yang B, Wang J, Liu Y, Yu L, Jiang Y. Immunomodulatory and anticancer activities of flavonoids extracted from litchi (Litchi chinensis Sonn) pericarp. Int Immunopharmacol. 2007 ; 7: 162-166
66. Kim JY, Kim JH, Byun JH, et al. Antioxidant and anticancer activities of water and ethanol extracts obtained from Sasa quelpaertensis Nakai. Life Sci J. 2013 ; 10: 1250-1254